当前位置:首页 - 行情中心 - 众生药业(002317) - 财务分析 - 现金流量表

众生药业

(002317)

  

流通市值:195.54亿  总市值:216.39亿
流通股本:7.68亿   总股本:8.50亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,458,926,554.94658,868,781.342,253,476,191.071,633,495,906.4
  收到的税费返还15,244,904.5206,536,650.776,538,916.59
  收到其他与经营活动有关的现金20,073,782.1813,805,340.07102,744,187.8139,525,156.55
  经营活动现金流入小计1,494,245,241.64672,674,121.412,362,757,029.651,679,559,979.54
  购买商品、接受劳务支付的现金296,077,715.23165,209,060.62598,016,179.93414,949,308.71
  支付给职工以及为职工支付的现金141,915,748.0586,150,449.72252,126,312.04195,278,770.6
  支付的各项税费101,769,641.3345,991,558.32196,918,615.14145,102,393.68
  支付其他与经营活动有关的现金412,728,804.76233,788,358.381,010,491,339.86769,244,380.81
  经营活动现金流出小计952,491,909.37531,139,427.042,057,552,446.971,524,574,853.8
  经营活动产生的现金流量净额541,753,332.27141,534,694.37305,204,582.68154,985,125.74
二、投资活动产生的现金流量:
  收回投资收到的现金484,080,868.7130,080,868.71,277,045,953.32757,950,191.91
  取得投资收益收到的现金12,926,976.69955,894.7122,085,754.520,609,266.49
  处置固定资产、无形资产和其他长期资产收回的现金净额5,615,351.062,005,5908,203,175.97,969,459.69
  收到的其他与投资活动有关的现金86.0267.1479.7579.74
  投资活动现金流入小计502,623,282.47133,042,420.551,307,334,963.47786,528,997.83
  购建固定资产、无形资产和其他长期资产支付的现金121,100,144.3848,410,357.59316,170,977.1193,178,273.01
  投资支付的现金799,000,000440,000,000945,000,000656,500,000
  投资活动现金流出小计920,100,144.38488,410,357.591,261,170,977.1849,678,273.01
  投资活动产生的现金流量净额-417,476,861.91-355,367,937.0446,163,986.37-63,149,275.18
三、筹资活动产生的现金流量:
  取得借款收到的现金21,627,714.1818,627,714.18327,946,995.65209,304,342.88
  收到其他与筹资活动有关的现金260,265.25163,876.8270,259,745.5968,429,904.49
  筹资活动现金流入小计21,887,979.4318,791,591398,206,741.24277,734,247.37
  偿还债务支付的现金212,014,28049,597,150304,285,470100,000,000
  分配股利、利润或偿付利息支付的现金170,118,489.3956,666.67170,311,295.4170,311,295.4
  支付其他与筹资活动有关的现金1,776,587.04966,070.28659,139,246.34531,576,061.53
  筹资活动现金流出小计383,909,356.4350,619,886.951,133,736,011.74801,887,356.93
  筹资活动产生的现金流量净额-362,021,377-31,828,295.95-735,529,270.5-524,153,109.56
四、汇率变动对现金及现金等价物的影响-41,578.85-20,914.64-30,491.28-15,840.3
五、现金及现金等价物净增加额-237,786,485.49-245,682,453.26-384,191,192.73-432,333,099.3
  加:期初现金及现金等价物余额977,893,369.27977,893,369.271,362,084,5621,362,084,562
  期末现金及现金等价物余额740,106,883.78732,210,916.01977,893,369.27929,751,462.7
补充资料:
  净利润106,746,970.3-266,704,568.89-
  资产减值准备-3,006,075.79-30,717,430.08-
  固定资产和投资性房地产折旧36,376,517.13-69,592,858.55-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧36,376,517.13-69,592,858.55-
  无形资产摊销29,391,541.49-52,808,122-
  长期待摊费用摊销130,740.22-1,032,881.22-
  处置固定资产、无形资产和其他长期资产的损失-6,187,070.22--6,049,345.32-
  固定资产报废损失28,164.82-1,155,813.89-
  公允价值变动损失23,943,057.03-19,489,239.27-
  财务费用260,785.59-2,309,369.55-
  投资损失-7,983,362.09--16,577,557.9-
  递延所得税10,825,159.85-12,439,193.82-
  其中:递延所得税资产减少4,792,740.86-9,120,186.13-
    递延所得税负债增加6,032,418.99-3,319,007.69-
  存货的减少-21,970,590.53-71,243,420.42-
  经营性应收项目的减少270,405,907.8--214,096,024.24-
  经营性应付项目的增加95,381,727.29--32,851,977.96-
  其他6,164,525.82-44,856,259.72-
  债务转为资本0-0-
  一年内到期的可转换公司债券0-0-
  融资租入固定资产0-0-
  现金的期末余额740,106,883.78-977,893,369.27-
  减:现金的期初余额977,893,369.27-1,362,084,562-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额-237,786,485.49--384,191,192.73-
公告日期2026-08-252026-04-292026-04-292025-10-31
审计意见(境内)标准无保留意见
TOP↑